Press event programme


Sechenov University and Akrikhin Russian Pharmaceutical Company

06 Jun , 12:00–12:15
Agreement signing ceremony
small passage, signing ceremony point 1 (next to conference hall D1)

Signing of a protocol of intent on further cooperation to jointly develop and invest in the creation of innovative Russian medicines for the treatment of type 2 diabetes mellitus and other metabolic disorders.

Representatives of the parties signing the agreement
Vadim Tarasov, Head of Innovative Pharmaceuticals; Director of the Institute of Translational Medicine and Biotechnology, Sechenov University
Denis Chetverikov, President, Akrikhin Russian Pharmaceutical Company